iCAD, Inc. ICAD announces that it has secured regulatory approval for its SecondLook® Digital by the State Food and Drug Administration in the People's Republic of China. The approval allows iCAD's SecondLook Digital computer-aided detection technology to be sold with GE Digital Mammography Systems in order to assist radiologists in distinguishing potential cancers from other anomalies on a mammogram.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in